Management of unresectable, locally advanced pancreatic adenocarcinoma.

about

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.

P2860

Q52688051-C99E9FBC-2655-4B1F-838E-D162C019EDE6

P2860

Management of unresectable, locally advanced pancreatic adenocarcinoma.

Item

http://www.wikidata.org/entity/Q39371353

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@en

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@nl

type

Item

label

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@en

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@nl

prefLabel

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@en

Management of unresectable, locally advanced pancreatic adenocarcinoma.

@nl

P1476

Management of unresectable, locally advanced pancreatic adenocarcinoma

@en

P2093

A Martínez

http://www.w3.org/2001/XMLSchema#string

M Hidalgo

http://www.w3.org/2001/XMLSchema#string

O Hernando

http://www.w3.org/2001/XMLSchema#string

R Yaya

http://www.w3.org/2001/XMLSchema#string

S Arévalo

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.

The concurrent chemoradiation paradigm--general principles.

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.

P2888

s12094-017-1679-1

P304

113-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1679-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Salgado

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28612202

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

Management of unresectable, locally advanced pancreatic adenocarcinoma.

about

P2860

P2860

Management of unresectable, locally advanced pancreatic adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921